Nicotine restores endothelial dysfunction caused by excess sFlt1 and sEng in an in vitro model of preeclamptic vascular endothelium: a possible therapeutic role of nicotinic acetylcholine receptor (nAChR) agonists for preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 5, 2010, Pages 464.e1-464.e6

  Mimura, Kazuya ^a   Tomimatsu, Takuji ^a   Sharentuya, Namuxila ^a   Tskitishvili, Ekaterine ^a   Kinugasa Taniguchi, Yukiko ^a   Kanagawa, Takeshi ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

nicotine; placental growth factor (PlGF); preeclampsia; soluble endoglin (sEng); soluble fms like tyrosine kinase 1 (sFlt1)

Indexed keywords

ENDOGLIN; NICOTINE; PLACENTAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; WOUND HEALING;

EID: 77951878948     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.01.037     Document Type: Article

References (54)

1. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
2. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
3. Robertson W.B., Brosens I., and Dixon H.G. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 93 (1967) 581-592
4. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
5. Yuan H.T., Haig D., and Karumanchi S.A. Angiogenic factors in the pathogenesis of preeclampsia. Curr Top Dev Biol 71 (2005) 297-312
6. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
7. Levine R.J., Thadhani R., Qian C., et al. Urinary placental growth factor and risk of preeclampsia. JAMA 293 (2005) 77-85
8. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
9. Chaiworapongsa T., Romero R., Kim Y.M., et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 17 (2005) 3-18
10. Hertig A., Berkane N., Lefevre G., et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 50 (2004) 1702-1703
11. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
12. Koga K., Osuga Y., Yoshino O., et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 88 (2003) 2348-2351
13. Chaiworapongsa T., Romero R., Espinoza J., et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190 (2004) 1541-1547
14. Powers R.W., Roberts J.M., Cooper K.M., et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 193 (2005) 185-191
15. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226 (1996) 324-328
16. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
17. Toporsian M., Gros R., Kabir M.G., et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96 (2005) 684-692
18. Bdolah Y., Sukhatme V.P., and Karumanchi S.A. Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights. Semin Nephrol 24 (2004) 548-556
19. Conde-Agudelo A., Althabe F., Belizán J.M., and Kafury-Goeta A.C. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 181 (1999) 1026-1035
20. Hammoud A.O., Bujold E., Sorokin Y., Schild C., Krapp M., and Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 192 (2005) 1856-1862
21. Jeyabalan A., Powers R.W., Durica A.R., Harger G.F., Roberts J.M., and Ness R.B. Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. Am J Hypertens 21 (2008) 943-947
22. Heeschen C., Jang J.J., Weis M., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7 (2001) 833-839
23. Cooke J.P. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sciences 80 (2007) 2347-2351
24. Darby T.D., McNamee J.E., and van Rossum J.M. Cigarette smoking pharmacokinetics and its relationship to smoking behavior. Clin Pharmacokinet 9 (1984) 435-449
25. Hill P., Haley N.J., and Wynder E.L. Cigarette smoking: carboxyhemoglobin, plasman nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. J Chronic Dis 36 (1983) 439-449
26. Jain R.K. Clearing the smoke on nicotine and angiogenesis. Nat Med 7 (2001) 775-777
27. Conklin B.S., Zhao W., Zhong D.S., and Chen C. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 160 (2002) 413-418
28. Heeschen C., Weis M., and Cooke J.P. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 110 (2002) 527-536
29. Goodwin A.M. In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res 74 (2007) 172-183
30. Frick M., Dulak J., Cisowski J., et al. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 170 (2003) 229-236
31. Imaizumi T., Itaya H., Nasu S., et al. Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha-an autocrine regulation of angiogenesis and inflammatory reactions. Thromb Haemost 83 (2000) 949-955
32. Ogburn P.L., Hurt R.D., Croghan I.T., et al. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obset Gynecol 181 (1999) 736-743
33. Wisborg K., Henriksen T.B., Jespersen L.B., and Secher N.J. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 96 (2000) 967-971
34. Oncken C., Dornelas E., Greene J., et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 112 (2008) 859-867
35. Ernst M., Moolchan E.T., and Robinson M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40 (2001) 630-641
36. Jonge W., and Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pathol 151 (2007) 915-929
37. Bainbridge S.A., Farley A.E., McLaughlin B.E., et al. Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta 23 (2002) 563-569
38. England L.J., Levine R.J., Mills J.L., Klebanoff M.A., Yu K.F., and Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol 189 (2003) 939-943
39. Bainbridge S.A., Belkacemi L., Dickinson M., Graham C.H., and Smith G.N. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol 169 (2006) 774-783
40. Baum M., Schiff E., Kreiser D., et al. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 183 (2000) 900-903
41. Kreiser D., Baum M., Seidman D.S., et al. End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatol 24 (2004) 213-217
42. Cudmore M., Ahmad S., Al-Ani B., et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115 (2007) 1789-1797
43. Dowling O., Rochelson B., Way K., Al-Abed Y., and Metz C.N. Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension. Mol Med 13 (2007) 576-583
44. Mehendale R., Hibbard J., Fazleabas A., and Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol 197 (2007) 363.e1-363.e5
45. Ahmad S., and Ahmed A. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis. Endothelium 12 (2005) 89-95
46. Fisher S.J. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2 (2004) 53
47. Zhou Y., McMaster M., Woo K., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
48. Athanassiades A., and Lala P.K. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta 19 (1998) 465-473
49. Desai J., Holt-Shore V., Torry R.J., Caudle M.R., and Torry D.S. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod 60 (1999) 887-892
50. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
51. Wang H., Liao H., Ochani M., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10 (2004) 1216-1221
52. Saeed R.W., Varma S., Peng-Nemeroff T., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201 (2005) 1113-1123
53. Speer P., Zhang Y., Gu Y., Lucas M.J., and Wang Y. Effects of nicotine on intercellular adhesion molecule expression in endothelial cells and integrin expression in neutrophils in vitro. Am J Obstet Gynecol 186 (2002) 551-556
54. Borzychowski A.M., Sargent I.L., and Redman C.W. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 11 (2006) 309-316